Condition (MeSH)
Superior Vena Cava Syndrome
ClinicalTrials.gov lists 3 trials for Superior Vena Cava Syndrome or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Superior Vena Cava Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Superior Vena Cava Syndrome trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2019 | 1 |
| 2014 | 1 |
| 2001 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Superior Vena Cava Syndrome trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Not applicable | 1 |
| Observational | 1 |
How many Superior Vena Cava Syndrome trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which serious adverse events do Superior Vena Cava Syndrome trials report? (5)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Abdominal pain | 1 | 1 |
| Constipation | 1 | 1 |
| Cough | 1 | 1 |
| Death due to disease | 1 | 1 |
| Dyspnea | 1 | 1 |
Which publications cover Superior Vena Cava Syndrome? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Inside-out access: a new method of lead placement for patients with central venous occlusions. | Heart rhythm | 2011 | Yes |
| Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy. | Neurology | 2020 | No |
| The Extended Dwell Peripheral Intravenous Catheter Is an Alternative Method of NICU Intravenous Access. | Advances in neonatal care : official journal of the National Association of Neonatal Nurses | 2018 | No |
| Radiotherapy in oncological emergencies--final results of a patterns of care study in Germany, Austria and Switzerland. | Acta oncologica (Stockholm, Sweden) | 2008 | No |
| The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. | Current opinion in cardiology | 2001 | No |
Showing 5 of 7 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.